ArticleAnalytical and bioanalytical chemistry2026
Encapsulation efficiency determination methods for the analysis of different antigenic peptides within phosphatidylserine-liposomes.
Article in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The prevalence of autoimmune diseases (AIDs) is increasing and persists in individuals of all ages as reported by Pisetsky (Nat Rev Nephrol, 2023). Only palliative treatments are currently available as the development of a treatment that selectively eliminates the immune system autoreaction, without affecting its normal functioning, is not an easy task. In this regard, an innovative strategy based on phosphatidylserine-liposomes (PS-Liposomes) loaded with the autoantigenic peptide that triggers the autoimmune attack has demonstrated efficacy in different AIDs as described by Almenara-Fuentes et al. (Nanomedicine 48, 2023) and Pujol-Autonell et al. (PLoS One 10, 2015). Encapsulation efficiency (EE) determination in liposomal therapeutic formulations is considered one of the most important attributes, as the encapsulated drug concentration is usually related to the treatment's effectiveness. In this regard, several methods have been described in the literature for the determination of specific peptides within liposomes. However, the described methodologies cannot usually be applied to other peptides with different properties. In this study, peptides with different lengths and physicochemical properties encapsulated in PS-Liposome formulations were used as models to evaluate several methods for both free and total antigen quantification. Different approaches for liposome lysis and subsequent total or encapsulated antigen quantification were studied. On the other hand, a comprehensive comparison of different centrifugal filters and an ultracentrifugation method was performed for free antigen determination. Identification and quantification of the autoantigenic peptides were performed by reversed-phase high-performance liquid chromatography with ultraviolet detection (RP-HPLC-UV). Results obtained for direct and indirect EE determinations were compared for PS-Liposome formulations, and the best conditions for each peptide were selected.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.